NCCTG N0879 (Alliance): A randomized phase II trial of carboplatin, paclitaxel, bevacizumab, with or without everolimus for therapy of metastatic malignant melanoma McWilliams, Robert R. , Allred, Jake , Kottschade, Lisa ... - ECC - Eur. J. Cancer - 2015 Abstract - Primary Endpoint - Primary Analysis - Experimental - N0879
